These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12358257)

  • 1. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia.
    Bauer TM; Schwacha H; Steinbrückner B; Brinkmann FE; Ditzen AK; Aponte JJ; Pelz K; Berger D; Kist M; Blum HE
    Am J Gastroenterol; 2002 Sep; 97(9):2364-70. PubMed ID: 12358257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
    Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE
    Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of plasma endotoxin levels in patients with cirrhosis.
    Chan CC; Hwang SJ; Lee FY; Wang SS; Chang FY; Li CP; Chu CJ; Lu RH; Lee SD
    Scand J Gastroenterol; 1997 Sep; 32(9):942-6. PubMed ID: 9299675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.
    Wang Z; Wang A; Gong Z; Biviano I; Liu H; Hu J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):410-416. PubMed ID: 31053499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.
    Wigg AJ; Roberts-Thomson IC; Dymock RB; McCarthy PJ; Grose RH; Cummins AG
    Gut; 2001 Feb; 48(2):206-11. PubMed ID: 11156641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test.
    Bauer TM; Schwacha H; Steinbrückner B; Brinkmann FE; Ditzen AK; Kist M; Blum HE
    J Hepatol; 2000 Sep; 33(3):382-6. PubMed ID: 11019993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.
    Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Triantos C; Vagianos CE; Spiliopoulou I; Kaltezioti V; Charonis A; Nikolopoulou VN; Scopa CD; Thomopoulos KC
    Eur J Clin Invest; 2012 Apr; 42(4):439-46. PubMed ID: 22023490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy.
    Schietroma M; Carlei F; Cappelli S; Amicucci G
    Ann Surg; 2006 Mar; 243(3):359-63. PubMed ID: 16495701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
    van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
    Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension.
    Gunnarsdottir SA; Sadik R; Shev S; Simrén M; Sjövall H; Stotzer PO; Abrahamsson H; Olsson R; Björnsson ES
    Am J Gastroenterol; 2003 Jun; 98(6):1362-70. PubMed ID: 12818282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
    Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
    Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption.
    Shindo K; Machida M; Miyakawa K; Fukumura M
    Am J Gastroenterol; 1993 Dec; 88(12):2084-91. PubMed ID: 8249977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel bacterial overgrowth and endotoxemia in cirrhosis.
    Wang J; Chen M; Sun G; Et Al
    Zhonghua Nei Ke Za Zhi; 2002 Jul; 41(7):459-61. PubMed ID: 12189115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients.
    Jalan R; Olde Damink SW; Ter Steege JC; Redhead DN; Lee A; Hayes PC; Deutz NE
    J Hepatol; 2011 Feb; 54(2):265-71. PubMed ID: 21067839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.
    Lata J; Novotný I; Príbramská V; Juránková J; Fric P; Kroupa R; Stibůrek O
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1111-3. PubMed ID: 17998837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.
    Pande C; Kumar A; Sarin SK
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1273-81. PubMed ID: 19302262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study.
    Scarpellini E; Abenavoli L; Cassano V; Rinninella E; Sorge M; Capretti F; Rasetti C; Svegliati Baroni G; Luzza F; Santori P; Sciacqua A
    Front Med (Lausanne); 2022; 9():872428. PubMed ID: 35559337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.
    Ghosh G; Jesudian AB
    J Clin Exp Hepatol; 2019; 9(2):257-267. PubMed ID: 31024208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial overgrowth in small intestine in patients with liver cirrhosis].
    Chesta J; Silva M; Thompson L; del Canto E; Defilippi C
    Rev Med Chil; 1991 Jun; 119(6):626-32. PubMed ID: 1844365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis.
    Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Zisimopoulos D; Maroulis I; Kontogeorgou E; Georgiou CD; Scopa CD; Thomopoulos KC
    Ann Hepatol; 2013; 12(2):301-7. PubMed ID: 23396742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.